Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Real-Life Anti-Tumour Necrosis Factor Experience in > 500 Paediatric United Kingdom Inflammatory Bowel Disease Patients

Autor: Merrick, Victoria M, Mortier, Kajal, Williams, Linda, Muhammed, Rafeeq, Auth, Marcus Kh, Elawad, Mamoun, Fell, John Me, Beattie, R Mark, Loganathan, Sabarinathan, Torrente, Franco, Morris, Mary-anne, Charlton, Charles, Croft, Nick M, Rodrigues, Astor, Furman, Mark, Vadamalayan, Babu, Jenkins, Huw, Zamvar, Veena, Mitton, Sally G, Chong, Sonny, Cosgrove, Mike, Akobeng, Anthony, Wilson, David, Russell, Richard K

Publikováno v: Merrick, V M, Mortier, K, Williams, L, Muhammed, R, Auth, M K, Elawad, M, Fell, J M, Beattie, R M, Loganathan, S, Torrente, F, Morris, M, Charlton, C, Croft, N M, Rodrigues, A, Furman, M, Vadamalayan, B, Jenkins, H, Zamvar, V, Mitton, S G, Chong, S, Cosgrove, M, Akobeng, A, Wilson, D & Russell, R K 2018, ' Real-Life Anti-Tumour Necrosis Factor Experience in > 500 Paediatric United Kingdom Inflammatory Bowel Disease Patients ', Journal of pediatric gastroenterology and nutrition, vol. 66, no. 2, pp. 274-280 . https://doi.org/10.1097/MPG.0000000000001679

OBJECTIVE: The aim of this study was to measure the effectiveness, safety, and use of anti-tumor necrosis Factor (TNF) therapy in pediatric inflammatory bowel disease in the United Kingdom (UK).METHODS: Prospective UK audit of patients newly starting

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3094::510c30d77b932548e1bc552ad3524b3c
https://hdl.handle.net/20.500.11820/22e0baec-3f16-4123-9023-c2782be8e250

Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children.

Autor: Auth, Marcus KH., Kim, Hyun Soo, Beste, Mechthild, Bonzel, Klaus E., Baumann, Ulrich, Ballauff, Antje, Wallot, Michael, Borchers, Tanja, Vester, Udo, Grasemann, Corinna, Hauffa, Berthold, Hoyer, Peter F., Gerken, Guido, Voit, Thomas, Auth, Marcus K H

Publikováno v: Journal of Pediatric Gastroenterology & Nutrition; Jan2005, Vol. 40 Issue 1, p54-59, 6p

Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease

Autor: Serra, Eva Gonçalves, Schwerd, Tobias, Moutsianas, Loukas, Cavounidis, Athena, Fachal, Laura, Pandey, Sumeet, Kammermeier, Jochen, Croft, Nicholas M, Posovszky, Carsten, Rodrigues, Astor, Russell, Richard K, Barakat, Farah, Auth, Marcus KH, Heuschkel, Robert, Zilbauer, Matthias, Fyderek, Krzysztof, Braegger, Christian, Travis, Simon P, Satsangi, Jack, Parkes, Miles, Thapar, Nikhil, Ferry, Helen, Matte, Julie C, Gilmour, Kimberly C, Wedrychowicz, Andrzej, Sullivan, Peter, Moore, Carmel, Sambrook, Jennifer, Ouwehand, Willem, Roberts, David, Danesh, John, Baeumler, Toni A, Fulga, Tudor A, Carrami, Eli M, Ahmed, Ahmed, Wilson, Rachel, Barrett, Jeffrey C, Elkadri, Abdul, Griffiths, Anne M, COLORS In IBD Group Investigators, Oxford IBD Cohort Study Investigators, INTERVAL Study, Swiss IBD Cohort Investigators, UK IBD Genetics Consortium, NIDDK IBD Genetics Consortium, Snapper, Scott B, Shah, Neil, Muise, Aleixo M, Wilson, David C, Uhlig, Holm H, Anderson, Carl A

Very-early-onset inflammatory bowel disease (VEO-IBD) is a heterogeneous phenotype associated with a spectrum of rare Mendelian disorders. Here, we perform whole-exome-sequencing and genome-wide genotyping in 145 patients (median age-at-diagnosis of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b82fd4939f713caf2695d26f101dd4d4

The immunological role of biliary epithelial cells in human liver transplant rejection

Autor: Scholz, Martin, Auth, Marcus KH, Bernd, H

Publikováno v: In Transplant Immunology 1997 5(2):142-151